Jan Elias Hansen

Jan Elias Hansen
Trustee 

Jan Hansen, PhD, is Vice President of the Evidence for Access Unit within Genentech’s US Medical Affairs.  Her unit is staffed with researchers who are uniquely positioned and skilled to address both the value and quality drivers of access in the US.  These researchers are tasked to consider both value and quality evidence when they develop access strategies and tactics.  Jan is a seasoned executive with more than twenty-five years of experience in the health care and pharmaceutical industries.  Jan’s pharmacoeconomics and health outcomes expertise were acquired throughout her vast career experiences in patient-based research, health care consulting, sales strategy and execution, and in both global and US focused outcomes research.  

She has held positions with increasing leadership responsibility at several well-regarded companies, including PCS-Pharmaceutical Data Services (now CVS-Caremark), NDC Health, Wolters Kluwer Health, Glaxo Wellcome (now GlaxoSmithkline), and Allergan.  Her professional accomplishments have been recognized by several professional organizations and resulted in numerous appointments, including: the University of Iowa College of Pharmacy Advisory Council, past Chair and current member of the University of Washington College of Pharmacy’s Corporate Advisory Council, Board member (representing Genentech) of the National Pharmaceutical Council (NPC), member of the Drug Information Association (DIA) Advisory Council of North America, past NPC Corresponding Officer and Research Committee member (representing Allergan), current member of the Academy Health Institution Council, and Foundation of Managed Care Pharmacy (FMCP) Board of Trustee.   

Jan is a licensed pharmacist and holds a Ph.D. in Pharmacy Administration from the University of South Carolina at Columbia.  She is also a speaker and guest lecturer on topics related to pharmacoeconomics and outcomes research. Jan’s ultimate passion is “building”; she takes great pride in building organizations and fostering young, innovative-thinking, yet applied researchers.   For Jan, there is no greater joy than watching these researchers flourish and making a difference to patients’ lives.